No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Kovai Medical Center and Hospital Limited (KMCH) is a prominent Indian entity offering a diverse range of hospital services. Its operations are segmented into two core areas: healthcare provision and education. Within its robust healthcare division, KMCH manages an extensive network of medical facilities. These cater to a vast array of medical specialties, encompassing critical care, dermatology, emergency services, endocrinology, diabetology, fertility and reproductive medicine, gastroenterology, hepatology, hematology, internal medicine, neonatology, nephrology, neurology, obstetrics and gynecology, pediatric surgery, pulmonology, psychological medicine, and rheumatology. Additionally, they provide comprehensive health check programs. The company also boasts advanced surgical capabilities, performing general, gastrointestinal, bariatric, and laparoscopic procedures, alongside highly specialized surgeries such as cardio-thoracic, orthopedic and joint replacement, neurosurgery, plastic and reconstructive, cosmetic, urology, spine, ENT/head and neck, dentistry/facio maxillary, and vascular surgeries. KMCH's infrastructure further includes state-of-the-art diagnostic services like interventional radiology, imaging sciences, nuclear medicine, and PET CT, as well as laboratory medicine facilities. Patients also benefit from physical medicine and rehabilitation services, and specialized cancer and ayurvedic wellness centers. Essential emergency and trauma services, coupled with organ transplant programs, complete their healthcare offerings. Beyond clinical care, KMCH contributes to medical education by operating a medical college in Coimbatore. Established in 1985, Kovai Medical Center and Hospital Limited is headquartered in Coimbatore, India.
www.kmchhospitals.comNo one on the platform currently holds KOVAI.BO.
No tracked institution reports a position in KOVAI.BO as of their last filing.
No one on the platform has traded KOVAI.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 14.9% | 16.3% | 15.7% | — | — | — |
| Rev. Growth % | 15.6% | 18.1% | ||||
| Profit Margin % | 15.4% | 13.7% | 12.4% | |||
| Free Cash Flow Margin % | 6.4% | 10.5% | 1.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $5.4B | — | $55.93 | $55.93–$55.93 | — | 1 |
| 2028 | $6.0B | +11.3% | $58.21 | $58.21–$58.21 | — | 1 |
| 2029 | $6.5B | +9.0% | $66.15 | $66.15–$66.15 | — | 1 |
| 2030 | $7.2B | +10.5% | $75.98 | $75.98–$75.98 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-06-03 | $9.65 | $54.55 | +465.3% |
| 2026-02-05 | $20.15 | $59.42 | +194.9% |
| 2025-11-06 | $20.15 | $53.79 | +166.9% |
| 2025-08-08 | $20.15 | $52.30 | +159.6% |
| 2025-05-28 | $9.65 | $49.99 | +418.0% |
| 2025-02-07 | $20.15 | $52.83 | +162.2% |
| 2024-11-08 | $20.15 | $46.32 | +129.9% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| KOVAI.BOKovai Medical Center and Hospital Limited | $6014.60 | -3.29% | $65.8B | — |
| FDC.BOFDC Limited | $349.35 | +2.15% | $56.8B | — |
| FDC.NSFDC Limited | $349.65 | +2.40% | $56.9B | — |
| INDRAMEDCO.BOIndraprastha Medical Corporation Limited | $354.90 | +0.18% | $32.5B | — |
| INDRAMEDCO.NSIndraprastha Medical Corporation Limited |
| $354.55 |
| -0.13% |
| $32.5B |
| — |
| SUPRIYA.BOSupriya Lifescience Ltd | $874.70 | -2.81% | $70.4B | — |
| SUPRIYA.NSSupriya Lifescience Limited | $874.95 | -2.97% | $70.4B | — |
Source: Financial Modeling Prep · peers by sector/industry